Therma Bright Inc.

Equities

THRM

CA8834261080

Advanced Medical Equipment & Technology

Market Closed - Toronto S.E. 03:39:43 2024-03-28 pm EDT 5-day change 1st Jan Change
0.02 CAD +33.33% Intraday chart for Therma Bright Inc. +33.33% -20.00%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Therma Bright Inc. Reports Earnings Results for the First Quarter Ended October 31, 2023 CI
Therma Bright Inc. Reports Earnings Results for the Full Year Ended July 31, 2023 CI
Ontario Securities Commission Issues Cease Trade Order Against Therma Bright Inc CI
Therma Bright Prepares Fda 513(G) Review Therma Bright Prepares FDA 513(G) Review Analyzer CI
Therma Bright Inc. Announces Venowave Pilot Tests with Existing and New Distribution Partners in the United States CI
Therma Bright Inc. Announces Chief Financial Officer Changes CI
Therma Bright Inc Signs Hero Lifecare to A U.S. Distribution Partner for Marketing and Selling the Venowave Device CI
Therma Bright Inc. Submits Updated FDA 510K Application Requesting Correction of Venowave Device's Intended Use, Labeling, and Description CI
Therma Bright Inc. Provides Update on Venowave for the United States and Texas Region CI
Therma Bright Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2023 CI
Therma Bright Inc. and Inretio Inc. Announces Successful Completion of Good Laboratory Practice Study for Its Breakthrough Preva™? Mechanical Thrombectomy Device CI
Therma Bright Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2023 CI
Therma Bright Inc. Provides an Update on Its Partnership with Inretio Inc CI
Therma Bright Inc. Reports Earnings Results for the First Quarter Ended October 31, 2022 CI
Therma Bright Inc. Auditor Raises 'Going Concern' Doubt CI
Therma Bright Inc. Reports Earnings Results for the Full Year Ended July 31, 2022 CI
Therma Bright Agrees to Buy Exclusive License for Patented Digital Cough-Based Technology to Detect Respiratory Diseases MT
Therma Bright Receives Payment for Initial Venowave Sales CI
Therma Bright Inc. Provides Update on FDA EUA Review Process CI
Therma Bright Inc. Provides Updates on Applications for Its AcuVid(TM) COVID-19 Rapid Antigen Saliva Test CI
Therma Bright Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2022 CI
Therma Bright Submits Health Canada Application for Its AcuVid(TM) COVID-19 Rapid Antigen Saliva Test for Point-of-Care CI
Therma Bright Provides Update on EUA Application Process For AcuVid COVID-19 Test MT
Therma Bright Inc. Provides Update on FDA EUA Application Process for Acuvid(TM) Covid-19 Rapid Antigen Saliva Test CI
Therma Bright to Submit Application to Health Canada for Approval of its AcuVid COVID-19 Rapid Antigen Saliva Test CI
Chart Therma Bright Inc.
More charts
Therma Bright Inc. is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. The Venowave is a medical compression pump that is lightweight, compact, battery operated, designed to treat and alleviate the symptoms associated with poor circulation.
More about the company
  1. Stock
  2. Equities
  3. Stock Therma Bright Inc. - Toronto S.E.
  4. News Therma Bright Inc.
  5. Therma Bright : Halted Ahead of News After Shares Rise 78%